Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän

Truncating CHRNG mutation… - Göteborgs universitet Till startsida
Till innehåll Läs mer om hur kakor används på gu.se

Truncating CHRNG mutations associated with interfamilial variability of the severity of the Escobar variant of multiple pterygium syndrome

Artikel i vetenskaplig tidskrift
Författare A. Kariminejad
N. Almadani
A. Khoshaeen
B. Olsson
Ali-Reza Moslemi
Homa Tajsharghi
Publicerad i Bmc Genetics
Volym 17
ISSN 1471-2156
Publiceringsår 2016
Publicerad vid Institutionen för biomedicin, avdelningen för patologi
Språk en
Länkar dx.doi.org/10.1186/s12863-016-0382-...
Ämnesord dna-sequencing data, to-epsilon-switch, acetylcholine-receptor, skeletal-muscle, fetal, lethal, innervation, phenotype, framework, subunit, Genetics & Heredity
Ämneskategorier Medicinsk genetik


Background: In humans, muscle-specific nicotinergic acetylcholine receptor (AChR) is a transmembrane protein with five different subunits, coded by CHRNA1, CHRNB, CHRND and CHRNG/CHRNE. The gamma subunit of AChR encoded by CHRNG is expressed during early foetal development, whereas in the adult, the. subunit is replaced by a epsilon subunit. Mutations in the CHRNG encoding the embryonal acetylcholine receptor may cause the non-lethal Escobar variant (EVMPS) and lethal form (LMPS) of multiple pterygium syndrome. The MPS is a condition characterised by prenatal growth failure with pterygium and akinesia leading to muscle weakness and severe congenital contractures, as well as scoliosis. Results: Our whole exome sequencing studies have identified one novel and two previously reported homozygous mutations in CHRNG in three families affected by non-lethal EVMPS. The mutations consist of deletion of two nucleotides, cause a frameshift predicted to result in premature termination of the foetally expressed gamma subunit of the AChR. Conclusions: Our data suggest that severity of the phenotype varies significantly both within and between families with MPS and that there is no apparent correlation between mutation position and clinical phenotype. Although individuals with CHRNG mutations can survive, there is an increased frequency of abortions and stillbirth in their families. Furthermore, genetic background and environmental modifiers might be of significance for decisiveness of the lethal spectrum, rather than the state of the mutation per se. Detailed clinical examination of our patients further indicates the changing phenotype from infancy to childhood.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?